Adherent: Can Agentic AI End the Regulatory Monitoring Grind?

Overview: How Adherent’s AI-Driven Regulatory Intelligence Platform Transforms Global Product Compliance

Adherent is an AI-driven regulatory intelligence platform that monitors changing requirements, connects them to products and markets, and turns relevant information into actionable insights. Its role in healthcare-related operations is product intelligence rather than clinical decision support. It addresses the information bottleneck created when teams must search fragmented sources, interpret lengthy documents, and determine which developments warrant attention, a process that can divert time from assessment and planning.

The platform combines a proprietary, human-verified intelligence database with AI agents that monitor updates, assess relevance, and extract structured requirements from complex text. Rather than presenting an undifferentiated stream of alerts, it maps information to product categories and markets, then prioritises changes according to urgency, potential business impact, and product exposure. This connects information discovery with practical assessment, helping distinguish consequential developments from background noise.

Operationally, Adherent can reduce repetitive research and document-review work while providing a clearer basis for prioritising follow-up activities. Its AI assistant, Ari, is positioned to execute workflow tasks so that human expertise remains focused on interpretation and decisions. The principal benefits are a lower administrative burden and more focused review of relevant changes; the vendor’s published efficiency claims should not be treated as independently demonstrated outcomes for healthcare workflows.

Last checked on October 17, 2026: Compliance & Risks now operates as Adherent following its June 16, 2026 rebrand and launch of an agentic AI product-compliance platform featuring the Ari assistant.

What is Adherent?

Adherent, formerly Compliance & Risks, is a regulatory intelligence and product-compliance platform that uses AI agents to monitor regulatory changes, assess their applicability to products and markets, extract requirements, and prioritise follow-up actions. It serves enterprise compliance, legal, and product-risk teams across industries; its relevance to healthcare and MedTech lies in product-compliance operations rather than clinical decision support. Its technical approach combines a proprietary, human-verified regulatory dataset with AI-driven workflow execution, while retaining internal experts’ final decision-making control.

Intended Use and Limitations

• Adherent identifies Stryker as a customer, providing a named MedTech adoption signal; this is a vendor-reported customer relationship, not a clinical endorsement or strategic partnership.

• Its published data-processing agreement permits customers or approved external auditors to audit Adherent’s implementation of its data-protection obligations at least annually.

• The services agreement specifies encryption of personal data in transit and customer data at rest in the C2P database and backup media.

• Adherent commits to using SOC 2/SSAE 18/ISAE 3402-certified data-centre facilities; this does not establish that Adherent’s application or organisation holds its own SOC 2 attestation.

• Its privacy policy identifies Adherent as generally acting as a data processor for customer information under GDPR, although the policy states that it was last updated in September 2018.

• Adherent describes its regulatory dataset as expert-validated and supports links between compliance evidence and underlying regulations, standards, and requirements, providing traceability for review.

• Founded in 2002, the company rebranded from Compliance & Risks to Adherent in June 2026, retaining the same company, regulatory expertise, and proprietary dataset.

• Luminate Capital invested in/acquired Compliance & Risks in 2021, and Adherent’s June 2026 engineering account continues to identify Luminate as its investor.